Health Canada approves GE’s cardiac spectral CT

| | Health Imaging | Cardiac Imaging

Health Canada has cleared GE Healthcare’s cardiac imaging platform, the Discovery CT750 HD FREEdom Edition.

Discovery CT750 HD FREEdom Edition includes Motion FREEdom, with motion correction via SnapShot Freeze; Calcium FREEdom, with coronary visualization using Gemstone Spectral Imaging (GSI) Cardiac; and Horizon FREE opportunities, with plaque material composition assessment and information for perfusion calculations.

SnapShot Freeze detects vessel motion and velocity to determine vessel position and correct the effects of motion during cardiac CT exams, according to Waukesha, Wis.-based GE.

The Discovery CT750 HD FREEdom Edition merges GE’s SnapShotPulse technology with GSI’s kV switching allowing for a registered spectral CT dataset. Spectral CT creates images of quantitative material density, which can then be synthesized into monochromatic energies. Calcium FREEdom allows coronary images with calcium suppression for patients with high calcium burden.

 

Related Content

Global shortage of nuclear imaging isotopes may be over
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT
FDA clears AI tool that flags signs of heart disease in chest CT scans
AI-enabled plaque assessments help cardiologists ID high-risk CAD patients
Abbott CGM sensors can now be worn during common imaging procedures
New data highlight long-term benefits of HeartFlow’s AI-based CAD evaluations

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup